Patent ID: 7192711

Claim:
A method of diagnosing a tumor in a subject, comprising: obtaining a sample comprising or potentially comprising a tumor cell from a subject; obtaining an antibody that binds immunologically to SEQ ID NO:2 or a nucleic acid segment that hybridizes to a nucleic acid encoding SEQ ID NO:2; admixing the sample with the antibody or the nucleic acid segment; and determining whether immunologic binding occurs between the antibody and SEQ ID NO:2 in the sample or hybridization occurs between the nucleic acid segment and a nucleic acid segment encoding SEQ ID NO:2 in the sample; wherein substantial lack of binding or hybridization is indicative of the presence of leukemia, glioma, melanoma, brain cancer, lung cancer, pancreatic cancer, bladder cancer, head and neck cancer, mesothelioma, ovarian cancer, sarcoma, childhood cancers, or breast cancer in the subject.